Medicare Enrolled

Dr. Wissam Abouzgheib, M.D.

Internal Medicine · Camden, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
3 COOPER PLZ RM 104, Camden, NJ 08103
8569688695
In practice since 2006 (20 years)
NPI: 1841246451 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Abouzgheib from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Abouzgheib? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Abouzgheib

Dr. Wissam Abouzgheib is an internal medicine specialist in Camden, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Abouzgheib performed 466 Medicare services across 438 unique beneficiaries.

Between the years covered by Open Payments, Dr. Abouzgheib received a total of $45,208 from 21 pharmaceutical and/or device companies across 131 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Abouzgheib is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 466 Medicare services $45,208 industry payments

Medicare Practice Summary

Medicare Utilization ↗
466
Medicare services
Bottom 29% in NJ for internal medicine
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
438
Unique beneficiaries
$88
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~23 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
57 $111 $450
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
38 $72 $308
Bronchoscopy with ultrasound and growth treatment
A procedure using a flexible tube with a camera and ultrasound to examine the lung airways and treat any growths found.
37 $55 $487
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
36 $67 $233
Endoscopic needle biopsy of windpipe, airway, or lung
A procedure where a needle is inserted through an endoscope to collect tissue samples from the windpipe, airway, or lung.
35 $132 $2,230
Chest fluid aspiration with imaging guidance
This procedure involves removing fluid from the chest cavity using imaging technology to guide the needle placement.
33 $92 $2,210
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
32 $95 $400
Bronchoscopy with ultrasound and lymph node sampling
A procedure using an endoscope and ultrasound to examine the lung airways and collect samples from 1 to 2 lymph nodes.
29 $163 $3,096
Initial hospital admission, low complexity
Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter.
29 $71 $279
Lung biopsy via endoscope, 1 lobe
A procedure to remove a small sample of lung tissue from one lobe using an endoscope for examination.
27 $39 $1,338
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
26 $42 $130
Computer-assisted navigation of lung airways
This procedure uses computer technology to guide an endoscope through the airways of the lungs for precise navigation.
23 $70 $4,028
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
19 $87 $350
Ultrasound scan of chest
An imaging test that uses sound waves to create pictures of the structures inside the chest.
18 $22 $84
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
15 $154 $450
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
12 $137 $529
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$45,208
Total received (2018-2024)
Avg $6,458/year across 7 years
Top 1% in NJ for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
21
Companies
131
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$35,973 (79.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$7,896 (17.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,339 (3.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$23,833
2023
$7,496
2022
$5,902
2021
$101
2020
$785
2019
$6,527
2018
$564

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$10,113
INTUITIVE SURGICAL, INC.
$8,600
Olympus Medical Systems Corporation
$4,391
Olympus America Inc.
$365
Gyrus ACMI, Inc.
$365
Top 3 companies account for 96.9% of 2024 payments
All-time payments by company (2018-2024) ›
Boston Scientific Corporation
$18,676
Intuitive Surgical, Inc.
$9,972
INTUITIVE SURGICAL, INC.
$8,600
Olympus Medical Systems Corporation
$4,391
Olympus America Inc.
$2,320
Gyrus ACMI, Inc.
$365
Genentech USA, Inc.
$200
Olympus Corporation
$163
Pulmonx Corporation
$130
GlaxoSmithKline, LLC.
$100
PFIZER INC.
$71
Novartis Pharmaceuticals Corporation
$61
AstraZeneca Pharmaceuticals LP
$39
Regeneron Healthcare Solutions, Inc.
$32
ERBE USA Inc
$15
Mylan Specialty L.P.
$15
Actelion Pharmaceuticals US, Inc.
$14
Teva Pharmaceuticals USA, Inc.
$13
Boehringer Ingelheim Pharmaceuticals, Inc.
$12
Sunovion Pharmaceuticals Inc.
$11
Veran Medical Technologies, Inc.
$10
Top 3 companies account for 82.4% of all-time payments
Associated products mentioned in payments ›
ANORO · Acquire · BEVESPI AEROSPHERE · BREO · CHANTIX · CINQAIR · DA VINCI SP · DAVINCI XI · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Da Vinci Surgical System · ELIQUIS · ERBE · EVIS EXERA II ULTRASONIC BRONCHOFIBERVIDEOSCOPE · General - Pulmonary · NUCALA · OFEV · Olympus Bronchoscopes · Olympus Respiratory Accessories · Pulmonx Endobronchial Valve EBV · SPiN Vision Video Processor · SVS · Single Use Guide Sheath Kit · Spin · Spiration Valve System · TRELEGY ELLIPTA · UPTRAVI · Utibron · XOLAIR · Xolair · Yupelri
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (80%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in internal medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for internal medicine in NJ.

Looking for an internal medicine specialist in Camden?
Compare internal medicine physicians in the Camden area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
4,166
Per 100K population
795.0
County median income
$86,384
Nearest hospital
COOPER UNIVERSITY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Abouzgheib is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 1% of NJ peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Abouzgheib experienced with initial hospital admission, moderate complexity?
Based on Medicare claims data, Dr. Abouzgheib performed 57 initial hospital admission, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Abouzgheib receive payments from pharmaceutical companies?
Yes. Dr. Abouzgheib received a total of $45,208 from 21 companies across 131 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Abouzgheib's costs compare to other internal medicine physicians in Camden?
Dr. Abouzgheib's average Medicare payment per service is $88. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Abouzgheib) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →